Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

Virology Journal

Volumn 7, Issue , 2010, Pages

  Scagnolari, Carolina ^a   Zingariello, Pompea ^b   Vecchiet, Jacopo ^b   Selvaggi, Carla ^a   Racciatti, Delia ^b   Taliani, Gloria ^c   Riva, Elisabetta ^d   Pizzigallo, Eligio ^b   Antonelli, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; MICRORNA; MICRORNA 1; MICRORNA 128; MICRORNA 196; MICRORNA 296; MICRORNA 30; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; RNA; UNCLASSIFIED DRUG; VIRUS RNA; ALPHA2A INTERFERON; ALPHA2B INTERFERON; MACROGOL DERIVATIVE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INJECTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS ACTIVATION; VIRUS LOAD; BIOSYNTHESIS; BLOOD; GENE EXPRESSION PROFILING; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL;

HEPATITIS C VIRUS;

ADULT; AGED; ALANINE TRANSAMINASE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; POLYETHYLENE GLYCOLS; VIRAL LOAD;

EID: 78149300921     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-311     Document Type: Article

References (30)

1. Interfering RNA and HIV: reciprocal interferences. P Corbeau, PLoS Pathog 2008 4 1000162 10.1371/journal.ppat.1000162 18818734
2. The roles of microRNAs in mammalian virus infection. R Grassmann KT Jeang, Biochim Biophys Acta 2008 1779 706 711 18549828
3. The evolution of RNAi as a defence against viruses and transposable elements. DJ Obbard KH Gordon AH Buck FM Jiggins, Philos Trans R Soc Lond B Biol Sci 2009 364 99 115 10.1098/rstb.2008.0168 18926973
4. Interferon modulation of cellular microRNAs as an antiviral mechanism. IM Pedersen G Cheng S Wieland S Volinia CM Croce FV Chisari M David, Nature 2007 449 919 922 10.1038/nature06205 17943132 (Pubitemid 47598616)
5. Differences in epidemiology, liver disease and treatment response among HCV genotypes. SJ Hadziyannis JS Koskinas, Hepatol Res 2004 29 129 135 10.1016/j.hepres.2004.02.011 15203075
6. Treatment failure in hepatitis C: mechanisms of non-response. AW Tai RT Chung, J Hepatol 2009 50 412 420 10.1016/j.jhep.2008.11.010 19070928
7. In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus. M Fernndez JA Quiroga J Martín M Herrero M Pardo MA Horisberger V Carrẽo, J Infect Dis 1999 180 262 267 10.1086/314859 10395838 (Pubitemid 30256304)
8. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection. AK Erickson S Seiwert M Gale Jr, Antivir Ther 2008 13 851 862 19043919
9. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha. JM Pawlotsky AG Hovanessian F Roudot-Thoraval N Robert M Bouvier G Babany J Duval D Dhumeaux, Antimicrob Agents Chemother 1996 40 320 324 8834873
10. Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C. JM Pawlotsky A Hovanessian F Roudot-Thoraval P Lebon N Robert M Bouvier G Babany J Duval D Dhumeaux, J Interferon Cytokine Res 1995 15 857 862 10.1089/jir.1995.15.857 8564707
11. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop. RT Chung M Gale Jr SJ Polyak SM Lemon TJ Liang JH Hoofnagle, Hepatology 2008 47 306 320 10.1002/hep.22070 18161743
12. Multiple sclerosis: Relating MxA transcription to anti-interferon - neutralizing antibodies. AL Hoffmann M Krumbholz H Faber T Kuempfel M Starck W Pöllmann E Meinl R Hohlfeld, Neurology 2007 68 958 959 10.1212/01.wnl. 0000257128.53775.62 17372138
13. Induction of MxA mRNA in patients with neuroendocrine tumors after interferon treatment. Lack of correlation with antitumor response. H Imam ET Janson A Gobl G Alm K Oberg, Anticancer Res 1995 15 2191 2195 8572623
14. Ribavirin improves early responses to peginterferon through improved interferon signalling. JJ Feld GA Lutchman T Heller K Hara JK Pfeiffer RD Leff C Meek M Rivera M Ko C Koh Y Rotman MG Ghany V Haynes-Williams AU Neumann TJ Liang JH Hoofnagle, Gastroenterology 2010 139 154 162 10.1053/j.gastro.2010.03. 037 20303352
15. Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy. C Scagnolari C Selvaggi L Chiavuzzo T Carbone L Zaffiri G d'Ettorre E Girardi O Turrizziani V Vullo G Antonelli, Intervirology 2009 52 107 114 10.1159/000218082 19439987
16. Analysis of continuous data from small samples. JM Bland DG Altman, BMJ 2009 338 3166 10.1136/bmj.a3166 19349342
17. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy. G Antonelli E Simeoni O Turriziani R Tesoro A Redaelli L Roffi L Antonelli M Pistello F Dianzani, J Interferon Cytokine Res 1999 19 243 251 10.1089/107999099314171 10213463
18. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA. HR Hubbell RS Liu BL Maxwell, Cancer Res 1984 44 3252 3257 6204744
19. Interferon-induced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells. G Roos T Leanderson E Lundgren, Cancer Res 1984 44 2358 2362 6722775
20. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. R Patzwahl V Meier G Ramadori S Mihm, J Virol 2001 75 1332 1138 10.1128/JVI.75.3.1332-1338.2001 11152506
21. Interferon alpha regulated gene expression in patients initiating interferon treatment for chronic Hepatitis C. X Ji R Cheung S Cooper Q Li HB Greenberg XS He, Hepatology 2003 37 610 621 10.1053/jhep.2003.50105 12601359
22. Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection. GC MacQuillan C Mamotte WD Reed GP Jeffrey JE Allan, J Med Virol 2003 70 219 227 10.1002/jmv.10381 12696108
23. Expression of biomarkers of interferon type I in patients suffering from chronic diseases. C Scagnolari F Bellomi S Trombetti M Casato M Carlesimo F Bagnato V Lavolpe R Bruno E Millefiorini L Antonelli E Girardi O Turriziani G Antonelli, Clin Exp Immunol 2007 147 270 276 10.1111/j.1365-2249.2006.03280.x 17223968
24. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection. GC MacQuillan WB de Boer MA Platten KA McCaul WD Reed GP Jeffrey JE Allan, J Med Virol 2002 68 197 205 10.1002/jmv.10182 12210408
25. MxA and PKR expression in chronic hepatitis C. G Giannelli G Guadagnino P Dentico G Antonelli S Antonaci, J Interferon Cytokine Res 2004 24 659 663 15684819
26. PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C. M Gerotto F Dal Pero G Bortoletto S Realdon A Ferrari S Boccato A Alberti, Antivir Ther 2004 9 763 770 15535414
27. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. M Sarasin-Filipowicz J Krol I Markiewicz MH Heim W Filipowicz, Nat Med 2009 15 31 33 10.1038/nm.1902 19122656
28. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes. V Meier S Mihm G Ramadori, J Med Virol 2008 80 1912 1918 10.1002/jmv.21310 18814253
29. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. MW Taylor T Tsukahara L Brodsky J Schaley C Sanda MJ Stephens JN McClintick HJ Edenberg L Li JE Tavis C Howell SH Belle, J Virol 2007 81 3391 3401 10.1128/JVI.02640-06 17267482
30. Interferon signaling and treatment outcome in chronic hepatitis C. M Sarasin-Filipowicz EJ Oakeley FH Duong V Christen L Terracciano W Filipowicz MH Heim, Hepatology 2008 48 1330 1333 10.1002/hep.22571 18821612